Direct in Vivo Intracellular Selection of Conformation-sensitive Antibody Domains Targeting Alzheimer's Amyloid-β Oligomers
- 1 April 2009
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 387 (3) , 584-606
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptideNature Reviews Molecular Cell Biology, 2007
- RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memoryNature, 2006
- Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivoNature Medicine, 2005
- Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseasesNature Cell Biology, 2004
- Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory lossProceedings of the National Academy of Sciences, 2003
- Triple-Transgenic Model of Alzheimer's Disease with Plaques and TanglesNeuron, 2003
- Alzheimer's Disease: Genes, Proteins, and TherapyPhysiological Reviews, 2001
- Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-proteinJournal of Alzheimer’s Disease, 2001
- Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's diseaseHistopathology, 2001
- Intraneuronal Aβ42 Accumulation in Human BrainThe American Journal of Pathology, 2000